FoundersClick
added new post
The first of three late-stage readouts on Neumora\'s lead drug candidate has ended in failure, wiping more than 80% off the value of the biotech.
The first of three late-stage readouts on Neumora\'s lead drug candidate has ended in failure, wiping more than 80% off the value of the biotech.
0 Comments
0 Shares
Please log in to Recommend, share and comment!